Twinning with Technology: Metabolic Digital Twins
Premise
GLP-1s had hit the market and the buzz was in full effect. The convergence of health and technology was accelerating and AI was changing the game for pharma. While digital twins were already starting to transform drug discovery and manufacturing, patient education was not being aggressively pursued via the latest technology and all the evidence suggested that patients and providers would benefit from such an exchange.
Precedent
Combining personalized patient avatars with quantified health data, a pilot platform was created to help patients better understand metabolic disease and the potential everyday opportunities to improve their health as well as the consequences of healthcare decisions. Complete with a suite of real world tools that were not just simulations but fed from live user data, the platform represented an interactive engagement supporting everything from mechanism of disease and what is happening within the body, to anonymized twin comparisons and patient empowerment and provider communications.


















